A carregar...
Periodic fasting starves cisplatin‐resistant cancers to death
Treatment of cancers with the cytotoxic agent cisplatin frequently evokes resistance, accompanied by rewiring of metabolic pathways, limiting its clinical use. Recent research by Obrist et al (2018) shows that cisplatin‐resistant growth of lung adenocarcinoma is particularly vulnerable to periodic f...
Na minha lista:
| Publicado no: | EMBO J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043846/ https://ncbi.nlm.nih.gov/pubmed/29875131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201899815 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|